在注意力缺陷/多动症障碍中,早期停止使用关法辛和昏昏欲睡之间存在关联
Kinuka Doi1, Rintaro Sogawa1, Yuko Eguchi2
1Department of Pharmacy, Saga University Hospital.
Biological & pharmaceutical bulletin
|June 23, 2024
概括
由于昏昏欲睡,关法辛的停用在注意力缺陷/多动症 (ADHD) 治疗的早期是常见的. 将guanfacine与甲基酸盐或atomoxetine结合使用可能会减少早期治疗中止.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床医学 临床医学
背景情况:
- 关法辛是一种ADHD药物,已知会引起昏昏欲睡.
- 另一种ADHD药物甲基酸盐与失眠有关.
- 关法辛诱导的嗜睡对治疗坚持性的影响尚不清楚.
研究的目的:
- 调查停止关法辛治疗的原因.
- 为了确定与因昏昏欲睡而停止关法西因治疗相关的因素.
主要方法:
- 在2017年7月至2021年12月期间对96名接受guanfacine治疗的患者进行的一项调查.
- 将停止关法辛治疗的患者分为早期 (≤70天) 和晚期 (>70天) 组.
- 早期和晚期组之间停止治疗的原因的比较,通过同时使用ADHD药物的分层.
主要成果:
- 在96名患者中,有49名患者停止了关法辛的治疗.
- 昏昏欲睡是治疗前70天 (44.0%) 中 discontinuation 的一个更常见的原因,与后期治疗 (8.3%) 相比.
- 在不服用其他ADHD药物的患者中,昏昏欲睡导致早期停药 (≤70天) 比较晚 (>70天) 停药要高得多.
结论:
- 昏昏欲睡是导致早期停止治疗多动症的重要因素之一.
- 同时使用甲基酸盐或阿托莫克赛丁可能会减轻关法辛诱导的昏昏欲睡,并减少早期停止治疗.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
659
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
5.7K
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168
Attention-Deficit/Hyperactivity Disorder
55
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
55
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Anxiolytic Drugs: Benzodiazepines and Buspirone
674
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
674
CNS Depressants: Barbiturates and Benzodiazepines
249
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
249
Sleepwalking and Sleep Talking
142
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
142
